Top

Journal of Neuro-Oncology

Published in:

01-12-2018 | Clinical Study

Platelet count is associated with outcome in cancer patients with stroke

Authors: Bernardo Cacho-Díaz, Héctor Spínola-Maroño, Laura G. Mendoza-Olivas, Myrna Candelaria

Published in: Journal of Neuro-Oncology | Issue 3/2018

Abstract

Introduction

Cerebrovascular disease (CVD) and cancer are among the most common causes of mortality worldwide, preceded only by ischemic heart disease (IHD). Thrombocytopenia was shown to be associated with poor outcomes in IHD and CVD in the general population. This study aimed to assess the relationship of thrombocytopenia with poor outcomes in cancer patients with CVD.

Materials and methods

Data on patients with concomitant CVD and cancer who were initially treated at a cancer referral center between January 2010 and December 2017 were included. Thrombocytopenia was defined as a platelet count < 150,000/mm³ during the first 24 h of CVD symptom onset. The IRB (CI/837/17) approved the review of clinical records.

Results

Among 268 cancer patients with CVD included in the study, 210 met the inclusion criteria. Median overall survival of the entire cohort was 7.2 months, which was significantly shorter in males (p = 0.029) and patients with hematologic tumors (p = 0.009), hemorrhagic CVD (p < 0.001), altered mental status (p < 0.001), and thrombocytopenia (p < 0.001). Multiple regression logistic analysis revealed that thrombocytopenia (risk ratio [RR] 1.6, 95% confidence interval [CI] 1.1–2.4) and altered mental status (RR 2.7, 95% CI 1.9–4.0) remained statistically significant risk factors for mortality.

Conclusion

In cancer patients with CVD, thrombocytopenia at the time of CVD diagnosis and altered mental status during initial clinical evaluation were associated with higher mortality, which should be confirmed in future studies.

Hankey GJ (2017) Stroke. The Lancet 389(10069):641–654. https://doi.org/10.1016/S0140-6736(16)30962-X CrossRef

GBD 2015 Mortality and causes of death collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet 388(10053):1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1 CrossRef

Sinkovic A, Majal M (2015) The impact of thrombocytopenia on outcome in patients with acute coronary syndromes: a single center retrospective study. Biomed Res Int. https://doi.org/10.1155/2015/907304 CrossRefPubMedPubMedCentral

McClure MW, Berkowitz SD, Sparapani R et al (1999) Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation 99(22):2892–2900. https://doi.org/10.1161/01.CIR.99.22.2892 CrossRefPubMed

Caixeta A, Dangas G-D, Mehran R et al (2011) Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J 161(2):298–306.e1. https://doi.org/10.1016/j.ahj.2010.10.035 CrossRefPubMed

Vora AN, Chenier M, Schulte PPJ et al (2014) Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 168(2):189–196. https://doi.org/10.1016/j.ahj.2014.04.010 CrossRefPubMed

Ayoub Karab O, Gbolahan M, Meera et al (2018) Impact of baseline thrombocytopenia on in-hospital outcomes after percutaneous coronary interventions: analysis over 70,000 patients. JACC 71(11:10–12):A1164CrossRef

Liu Shuai S, Chenxi Z, Yanyan et al (2018) The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: an analysis of 8,271 consecutive patients. Catheter Cardiovasc Interv 91(1):558–565. https://doi.org/10.1002/ccd.27498 CrossRefPubMed

Furlan JC, Fang J, Silver FL (2016) Outcomes after acute ischemic stroke in patients with thrombocytopenia or thrombocytosis. J Neurol Sci 362:198–203. https://doi.org/10.1016/j.jns.2016.01.044 CrossRefPubMed

10.

Mayda-Domac F, Mısırlı H, Yılmaz M (2010) Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis 19(1):66–72. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.03.003 CrossRefPubMed

11.

Riddle Matthew C et al (2018) American diabetes association: standards of medical care in diabetes. J Clin Appl Res Educ 41:13–27. https://doi.org/10.2337/dc18-SPPC01 CrossRef

12.

James PA et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 5(5):507–520. https://doi.org/10.1001/jama.2013.284427.311 CrossRef

13.

Posfai E, Marton I, Szoke A, Borbényi Z, Vecsei L, Csomor A et al (2014) Stroke in essential thrombocythemia. J Neurol Sci 336(1–2):260–262. https://doi.org/10.1016/j.jns.2013.10.016 CrossRefPubMed

14.

Park HK, Lee SH (2014) Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics. Neurol Sci 35(11):1801–1806. https://doi.org/10.1007/s10072-014-1843-0 CrossRefPubMed

15.

Sico JJ, Phipps MS, Concato J, Wells CK, Lo AC, Nadeau SE et al (2013) Thrombocytopenia and in-hospital mortality risk among ischemic stroke patients. J Stroke Cerebrovasc Dis 22(7):e99–e102. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.08.005 CrossRefPubMed

16.

Schiffer CA, Bohlke K, Delaney M et al (2018) Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guidelines update. J Clin Oncol 36:283–299. https://doi.org/10.1200/JCO.2017.76.1734 CrossRefPubMed

17.

Zhang YY, Chan DKY, Cordato D (2006) Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 114(6):378–383. https://doi.org/10.1111/j.1600-0404.2006.00709.x CrossRefPubMed

18.

Cestari DM, Weine DM, Panageas KS (2004) Stroke in patients with cancer: incidence and etiology. Neurology 62(11):2025–2030. https://doi.org/10.1212/01.WNL.0000129912.56486.2B CrossRefPubMed

19.

Zhang YY, Cordato D, Shen Q et al (2007) Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Disease 23:181–187. https://doi.org/10.1159/000097639 CrossRef

20.

Nguyen T, DeAngelis LM (2006) Stroke in cancer patients. Curr Neurol Neurosci Rep 6(3):187–192. https://doi.org/10.1007/s11910-006-0004-0 CrossRefPubMed

21.

Bang OY, Seok JM, Kim SG et al (2011) Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol 7(2):53–59. https://doi.org/10.3988/jcn.2011.7.2.53 CrossRefPubMedPubMedCentral

22.

Navi BB, Iadecola C (2018) Ischemic stroke in cancer patients: A review of an underappreciated pathology. Ann Neurol. https://doi.org/10.1002/ana.25227 (in press)CrossRefPubMedPubMedCentral

23.

Kneihsl M, Enzinger C, Wünsch G et al (2016) Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol 263(1):150–156. https://doi.org/10.1007/s00415-015-7954-6 CrossRefPubMed

24.

Rodrigues M, Costa R, Brito S, Pissarra A, Lourenço A, Grenho F, Campos L (2016) Ischemic stroke and cancer correlation: a stroke unit experience. Ann Oncol 28(5):40

Title: Platelet count is associated with outcome in cancer patients with stroke
Authors: Bernardo Cacho-Díaz
Héctor Spínola-Maroño
Laura G. Mendoza-Olivas
Myrna Candelaria
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-018-2982-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Platelet count is associated with outcome in cancer patients with stroke

Abstract

Introduction

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2018

Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade

Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer

The prediction of the tumor size of a vestibular schwannoma by clinical performance and vestibular function tests

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases